# CAPITAL SOLEIL 15
> **NDA021501** · New Drug Application · Sponsor: LOREAL USA · Approved 2006-10-02
## Drug
- **FDA Application Number:** NDA021501
- **Application type:** New Drug Application
- **Brand name:** CAPITAL SOLEIL 15
- **Generic name:** Avobenzone
- **Active ingredients:** AVOBENZONE; ECAMSULE; OCTOCRYLENE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Over-the-counter
- **Sponsor:** LOREAL USA
- **First approval:** 2006-10-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021501)
---
*MORVS · CC0 1.0*